News
TBIO
0.3777
-7.88%
-0.0323
Weekly Report: what happened at TBIO last week (0408-0412)?
Weekly Report · 1d ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Marin Software (NASDAQ:MRIN) stock is rocketing more than 67% after upgrading its integration with Microsoft Advertising. Shareholder meetings, clinical updates, an annual report and delisting plans are moving stocks this morning. The biggest pre-market stock movers on Wednesday morning are Marin Software and iCoreConnect.
Investorplace · 6d ago
Weekly Report: what happened at TBIO last week (0401-0405)?
Weekly Report · 04/08 09:24
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Tevogen Bio Holdings stock rose 85.5% to $4.86 during Thursday's pre-market session. Candel Therapeutics (NASDAQ:CADL) shares rose 27.97% and Healthcare Triangle stock rose 23.56% in the same session. Losers Telesis Bio (NASdaq:TBIO) stock fell 11.8% during the session. Q4 earnings came out today.
Benzinga · 04/04 12:09
Weekly Report: what happened at TBIO last week (0325-0329)?
Weekly Report · 04/01 09:24
TBIO Stock Earnings: Telesis Bio Misses EPS, Misses Revenue for Q4 2023
Telesis Bio reported earnings per share of -23 cents for the fourth quarter of 2023. The company reported revenue of $6.98 million. Telesis Bio's revenue was 0.33% lower than the analyst estimate for the same period. The biotech company also reported results for the third quarter.
Investorplace · 03/29 03:53
Telesis Bio GAAP EPS of -$0.61, revenue of $7M
Seeking Alpha · 03/28 21:03
*Telesis Bio 4Q R&D Expense $3.7M >TBIO
Dow Jones · 03/28 20:17
*Telesis Bio 4Q Rev $7M >TBIO
Dow Jones · 03/28 20:17
*Telesis Bio 4Q BioXp Kit Rev Exceeds $1M >TBIO
Dow Jones · 03/28 20:17
*Telesis Bio 4Q Loss $17.7M >TBIO
Dow Jones · 03/28 20:05
*Telesis Bio 4Q Loss/Shr 61c >TBIO
Dow Jones · 03/28 20:05
Weekly Report: what happened at TBIO last week (0318-0322)?
Weekly Report · 03/25 09:24
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Biolase (NASDAQ:BIOL) shares moved upwards by 61.5% to $0.24 during Friday's pre-market session. Eton Pharmaceuticals shares rose 15.46% during the day. Outlook Therapeutics and Nutriband also moved upwards. SINTX Techs shares declined by 34.0% in the pre- market.
Benzinga · 03/22 13:06
Weekly Report: what happened at TBIO last week (0311-0315)?
Weekly Report · 03/18 09:24
Telesis Bio Inc <TBIO.OQ> expected to post a loss of 22 cents a share - Earnings Preview
Telesis Bio Inc expected to report a 26.1% fall in quarterly revenue to $7 million from $9.47 million. The company is expected to post a loss of 22 cents a share. The one available analyst rating on the shares is 'buy' for Telesis Bio.
Reuters · 03/15 20:16
Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Cardlytics, Inc. Shares jumped 36.6% in pre-market trading after the company reported better-than-expected fourth-quarter earnings. Fisker shares dipped around 52% on Thursday following a report suggesting the company is preparing for a possible bankruptcy filing. Madrigal Pharmaceuticals, Inc.: Shares rose 26.9% after FDA approval of Rezdiffra.
Benzinga · 03/15 12:13
Weekly Report: what happened at TBIO last week (0304-0308)?
Weekly Report · 03/11 09:24
12 Health Care Stocks Moving In Wednesday's After-Market Session
SCWorx stock increased by 60.8% to $2.75 during Wednesday's after-market session. The company's market cap stands at $121.8 million. IO Biotech (NASDAQ:IOBT) stock moved upwards by 11.44% after Q4 earnings came out.
Benzinga · 03/06 21:31
Weekly Report: what happened at TBIO last week (0226-0301)?
Weekly Report · 03/04 09:24
More
Webull provides a variety of real-time TBIO stock news. You can receive the latest news about Telesis Bio through multiple platforms. This information may help you make smarter investment decisions.
About TBIO
Telesis Bio Inc. is a provider of ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) solutions. The Company provides automated multi-omic and synthetic biology solutions focused on providing applications to enable researchers to rapidly and reproducibly build or write high-quality synthetic DNA and messenger Ribonucleic Acid (mRNA) and short oligonucleotides that are ready to use in many downstream synthetic biology enabled markets. Its BioXp system consolidates, automates, and optimizes the entire synthesis, cloning and amplification workflow. Its on-market and its planned solutions include BioXp 3250 system, BioXp 9600 system, BioXp portal, BioXp De Novo kits, BioXp Select kits, BioXp Next Generation Sequencing kits, Benchtop reagents and Custom Gibson Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis (EDS) solutions. BioXp Select kits offer customers the ability to use non-Telesis Bio DNA while using the BioXp system to perform synthetic biology workflow applications.